241 related articles for article (PubMed ID: 26764012)
1. Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity.
Mommen GP; Marino F; Meiring HD; Poelen MC; van Gaans-van den Brink JA; Mohammed S; Heck AJ; van Els CA
Mol Cell Proteomics; 2016 Apr; 15(4):1412-23. PubMed ID: 26764012
[TBL] [Abstract][Full Text] [Related]
2. Ligandomes obtained from different HLA-class II-molecules are homologous for N- and C-terminal residues outside the peptide-binding cleft.
Kampstra ASB; van Heemst J; Janssen GM; de Ru AH; van Lummel M; van Veelen PA; Toes REM
Immunogenetics; 2019 Sep; 71(8-9):519-530. PubMed ID: 31520135
[TBL] [Abstract][Full Text] [Related]
3. Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells.
Peyron I; Hartholt RB; Pedró-Cos L; van Alphen F; Brinke AT; Lardy N; Meijer AB; Voorberg J
Haematologica; 2018 Jan; 103(1):172-178. PubMed ID: 29025906
[TBL] [Abstract][Full Text] [Related]
4. The human leukocyte antigen-presented ligandome of B lymphocytes.
Hassan C; Kester MG; de Ru AH; Hombrink P; Drijfhout JW; Nijveen H; Leunissen JA; Heemskerk MH; Falkenburg JH; van Veelen PA
Mol Cell Proteomics; 2013 Jul; 12(7):1829-43. PubMed ID: 23481700
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the HLA-DR peptidome from human dendritic cells reveals high affinity repertoires and nonconventional pathways of peptide generation.
Ciudad MT; Sorvillo N; van Alphen FP; Catalán D; Meijer AB; Voorberg J; Jaraquemada D
J Leukoc Biol; 2017 Jan; 101(1):15-27. PubMed ID: 27365532
[TBL] [Abstract][Full Text] [Related]
6. HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII.
van Haren SD; Herczenik E; ten Brinke A; Mertens K; Voorberg J; Meijer AB
Mol Cell Proteomics; 2011 Jun; 10(6):M110.002246. PubMed ID: 21467215
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ.
Hrdinová J; Verbij FC; Kaijen PHP; Hartholt RB; van Alphen F; Lardy N; Ten Brinke A; Vanhoorelbeke K; Hindocha PJ; De Groot AS; Meijer AB; Voorberg J; Peyron I
Haematologica; 2018 Jun; 103(6):1083-1092. PubMed ID: 29567779
[TBL] [Abstract][Full Text] [Related]
8. Pre-fractionation Extends but also Creates a Bias in the Detectable HLA Class Ι Ligandome.
Demmers LC; Heck AJR; Wu W
J Proteome Res; 2019 Apr; 18(4):1634-1643. PubMed ID: 30784271
[TBL] [Abstract][Full Text] [Related]
9. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
[TBL] [Abstract][Full Text] [Related]
10. IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4(+) T cells.
Ohno Y; Kitamura H; Takahashi N; Ohtake J; Kaneumi S; Sumida K; Homma S; Kawamura H; Minagawa N; Shibasaki S; Taketomi A
Cancer Immunol Immunother; 2016 Feb; 65(2):193-204. PubMed ID: 26759006
[TBL] [Abstract][Full Text] [Related]
11. Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome.
Mylonas R; Beer I; Iseli C; Chong C; Pak HS; Gfeller D; Coukos G; Xenarios I; Müller M; Bassani-Sternberg M
Mol Cell Proteomics; 2018 Dec; 17(12):2347-2357. PubMed ID: 30171158
[TBL] [Abstract][Full Text] [Related]
12. Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry.
Freudenmann LK; Marcu A; Stevanović S
Immunology; 2018 Jul; 154(3):331-345. PubMed ID: 29658117
[TBL] [Abstract][Full Text] [Related]
13. Tumour-associated antigenic peptides are present in the HLA class I ligandome of cancer cell line derived extracellular vesicles.
Kumar P; Boyne C; Brown S; Qureshi A; Thorpe P; Synowsky SA; Shirran S; Powis SJ
Immunology; 2022 Jun; 166(2):249-264. PubMed ID: 35318648
[TBL] [Abstract][Full Text] [Related]
14. Abundance, Betweenness Centrality, Hydrophobicity, and Isoelectric Points Are Relevant Factors in the Processing of Parental Proteins of the HLA Class II Ligandome.
Lorente E; Martín-Galiano AJ; Kadosh DM; Barriga A; García-Arriaza J; Mir C; Esteban M; Admon A; López D
J Proteome Res; 2022 Jan; 21(1):164-171. PubMed ID: 34937342
[TBL] [Abstract][Full Text] [Related]
15. Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation.
Löffler MW; Kowalewski DJ; Backert L; Bernhardt J; Adam P; Schuster H; Dengler F; Backes D; Kopp HG; Beckert S; Wagner S; Königsrainer I; Kohlbacher O; Kanz L; Königsrainer A; Rammensee HG; Stevanović S; Haen SP
Cancer Res; 2018 Aug; 78(16):4627-4641. PubMed ID: 29789417
[TBL] [Abstract][Full Text] [Related]
16. Interaction of HLA-DR and CD74 at the cell surface of antigen-presenting cells by single particle image analysis.
Karakikes I; Morrison IE; O'Toole P; Metodieva G; Navarrete CV; Gomez J; Miranda-Sayago JM; Cherry RJ; Metodiev M; Fernandez N
FASEB J; 2012 Dec; 26(12):4886-96. PubMed ID: 22889831
[TBL] [Abstract][Full Text] [Related]
17.
Gutierrez-Hoffmann MG; O'Meally RN; Cole RN; Tiniakou E; Darrah E; Soloski MJ
Front Med (Lausanne); 2020; 7():568. PubMed ID: 33043033
[TBL] [Abstract][Full Text] [Related]
18. Increased diversity of the HLA-B40 ligandome by the presentation of peptides phosphorylated at their main anchor residue.
Marcilla M; Alpízar A; Lombardía M; Ramos-Fernandez A; Ramos M; Albar JP
Mol Cell Proteomics; 2014 Feb; 13(2):462-74. PubMed ID: 24366607
[TBL] [Abstract][Full Text] [Related]
19. Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors.
Marcu A; Schlosser A; Keupp A; Trautwein N; Johann P; Wölfl M; Lager J; Monoranu CM; Walz JS; Henkel LM; Krauß J; Ebinger M; Schuhmann M; Thomale UW; Pietsch T; Klinker E; Schlegel PG; Oyen F; Reisner Y; Rammensee HG; Eyrich M
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599019
[TBL] [Abstract][Full Text] [Related]
20. Conformational variation of surface class II MHC proteins during myeloid dendritic cell differentiation accompanies structural changes in lysosomal MIIC.
Potolicchio I; Chitta S; Xu X; Fonseca D; Crisi G; Horejsi V; Strominger JL; Stern LJ; Raposo G; Santambrogio L
J Immunol; 2005 Oct; 175(8):4935-47. PubMed ID: 16210595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]